Proteases and extracellular environment

Mario Del Rosso; Gabriella Fibbi; Manfred Schmitt; Paolo Mignatti

doi:10.1055/s-0037-1616259

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(02): 190-191
DOI: 10.1055/s-0037-1616259

Theme Issue Editorial Focus

Schattauer GmbH

Proteases and extracellular environment

Mario Del Rosso

¹Department of Experimental Pathology and Oncology, University of Florence, Florence, Italy

,

Gabriella Fibbi

¹Department of Experimental Pathology and Oncology, University of Florence, Florence, Italy

,

Manfred Schmitt

²Klinische Forschergruppe, Frauenklinik der Technischen Universitaet Muenchen, Munich, Germany

,

Paolo Mignatti

³The Seymour Cohn Cardiovascular Surgery Research Laboratory, New York University School of Medicine, New York, New York, USA

› Author Affiliations

Abstract

Full Text

References

References
1 Willis R.. Pathology of Tumors. London: Butterworth and Company; 1998
2 Kadhim SA, Rees RC. Enhancement of tumor growth in mice: evidences for the involvement of host macrophages.. Cell Immunol 1984; 87: 259-69.
3 Leek RD, Harris AL. Tumor-associated macrophages in breast cancer.. J Mammary Gland Biol Neoplasia 2002; 7: 177-89.
4 Ben-Hur H. et al The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.. Anticancer Res 2002; 22: 1231-8.
5 Ronnov-Jenssen L, Petersen OW, Bissel M. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.. Physiol Rev 1996; 76: 69-125.
6 Olumi AF, Grossfeld GD, Hayward SW. et al Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.. Cancer Res 1999; 59: 5002-11.
7 Paget S. The distribution of secondary growths in cancer of the breast.. Lancet 1889; 1: 571-3.
8 Pucci-Minafra I, Minafra S, Tomasino RM. et al Collagen changes in the ductal infiltrating (scirrhous) carcinoma of the human breast.. J Submicrosc Cytol 1986; 18: 795-805.
9 Pucci-Minafra I, Luparello C, Andriolo M. et al A new form of tumor and foetal collagen with lamininbinding property.. Biochemistry 1993; 32: 7421-7.
10 Schorr SL, Schorr AM. Tumor-stroma interactions. Phenotypic and genetic alterations in mammary stroma: implications for tumor progression.. Breast Cancer Res 2001; 3: 373-9.
11 Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.. Science 2002; 295: 2387-92.
12 Mignatti P, Rifkin DB. Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology.. Adv Cancer Res 2000; 78: 103-57.
13 Montuori N. et al Soluble and cleaved forms of the urokinase receptor: degradation products or active molecules?. Thromb Haemost 2005; 93: 192-8.
14 Alfano D. et al The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.. Thromb Haemost 2005; 93: 205-11.
15 Chevanne M, Caldini R, Del Rosso M. PARP, a molecular switch of transcription, shows an attractive relationship with urokinase expression.. Thromb Haemost 2005; 93: 220-7.
16 Yan L, Zucker S, Toole BP. Roles of the multifunctional glycoprotein, Emmprin (basigin; cd147), in tumor progression.. Thromb Haemost 2005; 93: 199-204.
17 Kassiri Z, Khokha R. Regulation of cardiac extracellular matrix by metalloproteinases and their inhibitors.. Thromb Haemost 2005; 93: 212-19.